Geneos Wealth Management’s Credo Technology Group CRDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
4,548
-4,599
-50% -$909K 0.03% 489
2026
Q1
$859K Sell
9,147
-3,753
-29% -$457K 0.02% 547
2025
Q4
$1.86M Sell
12,900
-8,513
-40% -$1.31M 0.05% 366
2025
Q3
$3.12M Buy
21,413
+13
+0.1% +$1.59K 0.08% 277
2025
Q2
$1.98M Sell
21,400
-4,575
-18% -$267K 0.05% 374
2025
Q1
$1.04M Buy
25,975
+25,908
+38,669% +$1.61M 0.03% 452
2024
Q4
$4.5K Buy
+67
New +$3.33K ﹤0.01% 2376

Other funds holding CRDO

Geneos Wealth Management's CRDO Position: Q2 2026 in Review

Geneos Wealth Management reduced its Credo Technology Group (CRDO) stake by 50% in Q2 2026, selling an estimated $909K and leaving 4,548 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #489.

Geneos Wealth Management first reported a position in CRDO in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.12M in Q3 2025. 984 funds tracked by Wall St. Rank hold CRDO as of Q2 2026.

  • Geneos Wealth Management held 4,548 shares of Credo Technology Group worth $1.24M as of Q2 2026.
  • Geneos Wealth Management sold 4,599 Credo Technology Group shares in Q2 2026, an estimated $909K.
  • Credo Technology Group made up 0.03% of Geneos Wealth Management's portfolio in Q2 2026, its #489 holding.
  • Geneos Wealth Management first reported a position in Credo Technology Group in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's Credo Technology Group position peaked at $3.12M in Q3 2025.
  • 984 funds tracked by Wall St. Rank held Credo Technology Group as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.